author-photo

Gerald W. Chodak

University of Chicago
Weiss Memorial Hospital

155

Papers

6536

Citations

Citation Trend

Filter By

Papers (155) Sort By

Journal Conference Others

Overall survival (OS) benefit with sipuleucel-T by baseline PSA: An exploratory analysis from the phase III IMPACT trial.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial

2013 Urology
Show All
- Source
- Cite
- Save
Citations (182)
Prostatic Diseases and Male Voiding DysfunctionEditorial Comment

2013 Urology
- Gerald W. Chodak
Show All
- Source
- Cite
- Save
Citations (0)
Overall Survival Benefit with Sipuleucel-T by Baseline Prostate-Specific Antigen (PSA): An Exploratory Analysis from Three Phase 3 Trials

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Do “Rapid” PSA Assays Reduce Anxiety and Stress of Prostate Cancer Patients Undergoing Regular Review? A Prospective Evaluation

2008 Urology
Show All
- Source
- Cite
- Save
Citations (12)
Natural history and expectant management of prostate cancer

2008
- Jonathan Osborn
- Gerald W. Chodak
Show All
- Source
- Cite
- Save
Citations (0)
Is the increase in orchiectomy for prostate cancer patients appropriate

2008 Cancer
- Gerald W. Chodak
Show All
- Source
- Cite
- Save
Citations (2)
Combined Androgen Blockade in Advanced Prostate Cancer: Looking Back to Move Forward

2007 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (12)
Breast Cancer Screening, Commentary 1

2006
- Heidi Malm
- Gerald W. Chodak
Show All
- Source
- Cite
- Save
Citations (0)
Assessment of American urologists’ approach to hormonal management of prostate cancer

2006 Urology
Show All
- Source
- Cite
- Save
Citations (1)